Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration


Autoria(s): Chakravarthy, Usha; Adamis, A.P.; Jr, Cunningham E.T.; Goldbaum, M.; Guyer, D.R.; Katz, B.; Patel, M.
Data(s)

01/09/2006

Identificador

http://pure.qub.ac.uk/portal/en/publications/year-2-efficacy-results-of-2-randomized-controlled-clinical-trials-of-pegaptanib-for-neovascular-agerelated-macular-degeneration(3b8d2c68-3af4-4f38-adc4-4ce7aefbe8a2).html

http://dx.doi.org/10.1016/j.ophtha.2006.02.064

http://www.scopus.com/inward/record.url?scp=33747891752&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Chakravarthy , U , Adamis , A P , Jr , C E T , Goldbaum , M , Guyer , D R , Katz , B & Patel , M 2006 , ' Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration ' Ophthalmology , vol 113 (9) , no. 9 , pp. 1508-1521 . DOI: 10.1016/j.ophtha.2006.02.064

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2731 #Ophthalmology
Tipo

article